from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv3248c/sahH

LFCtreatmentdescriptionclass of inhibitor

-1.347

Amikacinug/mL Amikacintranslation

-0.734

Cap5-10ug/mL Capreomycintranslation

-0.910

Rox10-50 ug/mL Roxithromycintranslation

0.572

SM2-5 ug/mL Streptomycintranslation

-0.910

Tet5-10 ug/mL Tetracyclinetranslation

-1.347

Rif0.2-5ug/mL Rifampicintranscription

-1.361

Rifp0.1-0.5ug/mL Rifapentinetranscription

-2.951

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.935

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.228

CPZ10-50 ug/mL Chlorpromazinerespiration

0.370

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.277

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.745

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.300

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.383

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.159

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.415

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

-0.199

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.078

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

1.016

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

-1.492

KCN5-20 ug/mL Potassium cyaniderespiration

0.426

NaN30.2-2 mM Sodium aziderespiration

0.176

Nigericin50 uM Nigericinrespiration

-0.523

TRC10-150 ug/mL Triclosanrespiration

-0.910

TRZ10-25 ug/mL Thioridazinerespiration

-0.807

Valinomycin0.5-10 uM Valinomycinrespiration

0.041

ZnSO42 mM ZnSO4respiration

1.141

menadione6-10 ug/mL Menadionerespiration

0.767

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

0.172

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

0.386

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

0.286

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

0.087

NRP_1Non-replicating persistence stage 1dosRassociated

0.642

Amp0.2mg/mL AmpicillincellWall

0.229

Cephalexin20-100 ug/mL CephalexincellWall

0.435

Cerulenin0.32-5 ug/mL CerulenincellWall

0.632

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

0.631

EMB10-20 ug/mL EthambutolcellWall

0.418

Eta12-40 ug/mL EthionamidecellWall

0.438

INH0.2-0.4 ug/mL IsoniazidcellWall

1.101

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-1.206

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.870

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-1.440

BZA0.12 mg/mL BenzamidearomaticAmides

-0.933

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

-0.816

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

-0.319

H2O24 mM hydrogen peroxideDNAdamaging

0.869

Levo10 ug/mL LevofloxacinDNAdamaging

0.841

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

2.460

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.641

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.582

UVUV-irradiationDNAdamaging

-0.655

ARP41-4 ug/mL Antitubercular compound ARP4?

0.425

Antimycin12.5-50 ug/mL Antimycin A?

0.160

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

0.466

PA_110-50 ug/mL Antitubercular compound PA-1?

0.426

PA_2110-50 ug/mL Antitubercular compound PA-21?

-1.509

PA8240.2-2 ug/mL PA-824?

0.254

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.365

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

0.336

Verapamil50 uM Verapamil?

0.743

mercaptoethanol2 mM 2-Mercaptoethanol?

0.252

methoxatin10-20 ug/mL Methoxatin?